Latest News & Features
Americas
Mark Remus of Brinks Gilson & Lione discusses two patent-related challenges for generic pharmaceutical companies and how they might be overcome. 3 September 2018
Americas
Christopher Viehbacher was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 31 August 2018
Americas
Iana Dimkova was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the investment section, as LSIPR reports. 30 August 2018
article
Jean-François Formela was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 29 August 2018
Big Pharma
Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 28 August 2018
Americas
Bryan Roberts was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 27 August 2018
Americas
Jim Tananbaum was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 24 August 2018
Americas
Craig Muir was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 23 August 2018
Big Pharma
The European Commission’s proposed export waiver for supplementary protection certificates is likely to face opposition and may be delayed by EU parliamentary changes, says Trevor Cook of WilmerHale. 23 August 2018
Americas
Brian Anderson was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 22 August 2018